Rimsa

Rimsa (Representaciones e Investigaciones Médicas, S.A. de C.V.) is a prominent Mexican pharmaceutical company focused on the development and commercialization of branded generic drugs. The company established a strong market position in Mexico through a diverse portfolio covering therapeutic areas such as pain management, women's health, and respiratory diseases. In 2016, Rimsa was acquired by Teva Pharmaceutical Industries for $2.3 billion, marking one of the largest pharmaceutical acquisitions in Latin America at the time. While the acquisition was followed by significant litigation regarding manufacturing practices and regulatory filings, the company's assets continue to serve as a foundation for Teva's operations in the Mexican market. Rimsa operates significant manufacturing facilities in Guadalajara and remains a key provider of affordable medications in the region.